Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial. - Slørdahl KS; Puco K; Falk RS; Dyvik I; Brabrand S; Niehusmann P; Steinskog ESS; Blix ES; Flobak Å; Oppedal IA; Meltzer S; Torkildsen CF; et al. (Acta oncologica (Stockholm, Sweden), 2026)